Skip to main content
Caplight Logo









Pangaea Data

Pangaea Data

Private
LondonHealthcare & Life Scienceshttps://www.pangaeadata.ai/

Last Round

Strategic

May 27, 2025

Company Overview

Pangaea Data is a life sciences technology company that provides an AI-driven software platform to help healthcare providers and pharmaceutical companies identify undiagnosed, misdiagnosed, or miscoded patients for clinical trials and treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, EHR & EMR, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

electronic health recordEHRclinical intelligencepatient identificationmedical AIhealthcare analyticsunstructured data analysisclinical decision supportnatural language processingNLPprecision medicineclinical trial recruitmentAI scribehealth techB2B SaaSAI agent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pangaea Data Comparables

Compare Pangaea Data with similar companies based on industry and business-model similarity.

Pangaea Data comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Savana
85%
Averbis GmbH
83%
Clinithink
83%

Pangaea Data Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 27, 2025
SeedJan 28, 2021
SeedDec 20, 2019

Key People

Founding team and executive leadership

Carlos Pittol

Chief Operating Officer

Executive Team

Pangaea Data Investors

Notable investors and investment history

Pangaea Data investors
InvestorRounds
Ascension VenturesSeed
Salica InvestmentsSeed
IQ CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2025

    Next-generation platform launched to close care gaps and improve patient outcomes.

  • Aug 30, 2025

    Platform integrated with NVIDIA's comprehensive AI stack and runs on Microsoft Azure.

Pangaea Data Filings

Explore SEC and related filing metadata, where available.

Pangaea Data filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pangaea Data's valuation, stock price, and market status.

Is Pangaea Data a public or private company?

Pangaea Data is a private company.

What is the current stock price of Pangaea Data?

Pangaea Data is a private company with no public stock price. No recent secondary market data is available.

How much is Pangaea Data worth (valuation)?

Valuation information for Pangaea Data is not publicly available.

Can I buy Pangaea Data stock?

Pangaea Data shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pangaea Data's last funding round?

Pangaea Data's most recent funding round was Strategic on May 27, 2025.

Who are the main investors in Pangaea Data?

Key investors in Pangaea Data include IQ Capital.

Will Pangaea Data IPO soon?

No public IPO plans have been announced for Pangaea Data.

How can I track Pangaea Data secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pangaea Data's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range13
Year Founded2018
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?